Aveanna Healthcare (NASDAQ:AVAH) Sees Strong Trading Volume - Here's Why

Key Points

• Aveanna Healthcare shares saw a 26% volume increase, with about 2.19 million shares traded, while the stock closed at $13.02.
• The company exceeded quarterly expectations, reporting $0.22 in earnings per share versus the $0.17 consensus and revenue of $670.48 million, above estimates of $638.61 million.
• Analyst sentiment remains positive, with an average “Moderate Buy” rating and a $11.78 price target, although insiders sold more than 31.18 million shares worth approximately $214.6 million over the past 90 days.

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) saw strong trading volume on Friday . Approximately 2,194,922 shares changed hands during trading, an increase of 26% from the previous session's volume of 1,741,440 shares.The stock last traded at $13.02 and had previously closed at $12.97.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Raymond James Financial upped their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a "strong-buy" rating in a research note on Friday, August 14th. Truist Financial lifted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. Barclays boosted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an "overweight" rating in a report on Thursday, July 9th. Weiss Ratings restated a "hold (c+)" rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Finally, Royal Bank Of Canada upgraded Aveanna Healthcare from a "sector perform" rating to an "outperform" rating and set a $10.00 price objective for the company in a research report on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of "Moderate Buy" and an average price target of $11.78.

Aveanna Healthcare Price Performance

The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock's 50-day moving average price is $9.46 and its 200-day moving average price is $7.88. The company has a market capitalization of $2.90 billion, a price-to-earnings ratio of 10.80, a price-to-earnings-growth ratio of 0.92 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Equities research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In related news, major shareholder Paul R. Vigano sold 3,000,000 shares of Aveanna Healthcare stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider directly owned 190,130 shares in the company, valued at $1,522,941.30. This trade represents a 94.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the business's stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $19,376,470.35. Following the sale, the insider directly owned 10,112,123 shares of the company's stock, valued at $80,998,105.23. This represents a 19.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 31,180,664 shares of company stock worth $214,607,160 over the last 90 days. 5.30% of the stock is owned by insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. AQR Capital Management LLC boosted its stake in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company's stock valued at $142,000 after acquiring an additional 4,602 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Aveanna Healthcare by 8.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company's stock valued at $1,842,000 after acquiring an additional 25,974 shares during the last quarter. Jane Street Group LLC lifted its stake in shares of Aveanna Healthcare by 522.0% in the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company's stock valued at $407,000 after purchasing an additional 63,010 shares during the period. Creative Planning lifted its stake in shares of Aveanna Healthcare by 15.1% in the 2nd quarter. Creative Planning now owns 47,025 shares of the company's stock valued at $246,000 after purchasing an additional 6,171 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Aveanna Healthcare by 65.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company's stock worth $828,000 after purchasing an additional 62,348 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source